These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5171936)

  • 1. Further studies on the mode of action of amantadine.
    Strömberg U; Svensson TH
    Acta Pharmacol Toxicol (Copenh); 1971; 30(3):161-71. PubMed ID: 5171936
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.
    Svensson TH
    Eur J Pharmacol; 1973 Sep; 23(3):232-8. PubMed ID: 4746740
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the locomotor stimulant properties of amantadine and l- and d-amphetamine in mice.
    Thornburg JE; Moore KE
    Neuropharmacology; 1972 Sep; 11(5):675-82. PubMed ID: 4151250
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
    Maj J; Sowińska H; Baran L; Sarnek J
    Eur J Pharmacol; 1974 Apr; 26(1):9-14. PubMed ID: 4857604
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease.
    Farnebo LO; Fuxe K; Goldstein M; Hamberger B; Ungerstedt U
    Eur J Pharmacol; 1971 Sep; 16(1):27-38. PubMed ID: 5157529
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Responses of cortical pyramidal tract cells to amantadine and amphetamine after depletion of central catecholamines.
    Stone TW
    Br J Pharmacol; 1975 Jun; 54(2):244P-245P. PubMed ID: 1148533
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons.
    Fuxe K; Holmstedt B; Jonsson G
    Eur J Pharmacol; 1972 Jul; 19(1):25-34. PubMed ID: 4403108
    [No Abstract]   [Full Text] [Related]  

  • 8. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
    Von Voigtlander PF; Moore KE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):542-52. PubMed ID: 4687219
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine oxidase (MAO)-A but not MAO-B inhibitors potentiate tyramine-induced catecholamine release from PC12 cells.
    Youdim MB
    J Neurochem; 1990 Feb; 54(2):411-4. PubMed ID: 2299343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and biochemical effects of d-and 1-amphetamine on central catecholamine neurons.
    Svensson TH
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 271(2):170-80. PubMed ID: 4257153
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat.
    Baldessarini RJ; Lipinski JF; Chace KV
    Biochem Pharmacol; 1972 Jan; 21(1):77-87. PubMed ID: 5058704
    [No Abstract]   [Full Text] [Related]  

  • 13. On the mode of action of amantadine.
    Stromberg U; Svensson TH; Waldeck B
    J Pharm Pharmacol; 1970 Dec; 22(12):959-62. PubMed ID: 4395528
    [No Abstract]   [Full Text] [Related]  

  • 14. Central nervous system effects of fenfluramine hydrochloride.
    Ziance RJ; Sipes IG; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1972 Jan; 180(1):110-7. PubMed ID: 5062254
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: The effect of psychotropic drugs on the dopa potentiation test in mice.
    Berendsen H; Leonard BE; Rigter H
    Br J Pharmacol; 1974 Nov; 52(3):432P-433P. PubMed ID: 4458854
    [No Abstract]   [Full Text] [Related]  

  • 16. Amantadine may stimulate dopamine and noradrenaline receptors.
    Papeschi R
    Neuropharmacology; 1974 Jan; 13(1):77-83. PubMed ID: 4522901
    [No Abstract]   [Full Text] [Related]  

  • 17. Amantadine and apomorphine: interactions on striatal dopamine receptors.
    Cox B
    Proc West Pharmacol Soc; 1975; 18():162-7. PubMed ID: 1237137
    [No Abstract]   [Full Text] [Related]  

  • 18. Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
    Papeschi R; Randrup A
    Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):137-57. PubMed ID: 4800160
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).
    Johnson GA; Boukma SJ; Kim EG
    J Pharmacol Exp Ther; 1970 Jan; 171(1):80-7. PubMed ID: 5410940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.